Newsroom | 5981 results
Sorted by: Latest
-
Oryon Cell Therapies Appoints Kenny Choi, Ph.D. as Chief Technical Officer
WATERTOWN, Mass.--(BUSINESS WIRE)--Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson’s disease and other neurodegenerative disorders, today announced the appointment of Kenny Choi, Ph.D., as Chief Technical Officer (CTO). Dr. Choi will lead Oryon’s technical operations and Chemistry, Manufacturing, and Controls (CMC) strategy, including transfer of the manufacturing process for the company’s autolog...
-
Mission Therapeutics and NeuraLight Partner to Bring Precision Brain Function Biomarkers to a Global Parkinson's Disease Clinical Trial
CAMBRIDGE, England & NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Mission Therapeutics, a clinical-stage biotechnology company developing first-in-class therapeutics that enhance mitophagy to protect cell and organ health and NeuraLight, a leader in precision brain function measures, today announced a partnership to deploy NeuraLight's brain function biomarker assessments across Mission's multinational trial of MTX325 in Parkinson's disease. MTX325 is a first-in-class, orally bioavailable and...
-
Riassunto: Misurazione dei muscoli con risonanza magnetica quantitativa: un nuovo studio pubblicato su Neurology amplia le prove a sostegno dell’uso dei biomarcatori di imaging nella SBMA
LINKÖPING, Svezia--(BUSINESS WIRE)--AMRA Medical è lieta di annunciare la pubblicazione di una nuova ricerca nella rivista Neurology, a dimostrazione del potenziale della risonanza magnetica total body quantitativa per misurare la progressione dell'atrofia muscolare spinale e bulbare (SBMA), una rara patologia neuromuscolare a lenta progressione. La ricerca è stata selezionata anche per la copertina del numero, offrendo maggiore visibilità a questo importante lavoro di ricerca delle patologie n...
-
Samenvatting: Spieren meten met kwantitatieve MRI: nieuwe studie gepubliceerd in Neurology breidt het bewijs uit voor het gebruik van MRI-biomarkers bij SBMA
LINKÖPING, Zweden--(BUSINESS WIRE)--AMRA Medical kondigt verheugd aan dat nieuw onderzoek in Neurology is gepubliceerd. Het onderzoek laat het potentieel zien van kwantitatieve MRI van het hele lichaam voor de ziekteprogressiemeting bij spinale en bulbaire spieratrofie (SBMA), een zeldzame, progressieve neuromusculaire aandoening. Het onderzoek werd bovendien geselecteerd voor de omslag van dit nummer, wat getuigt van het belangrijke werk op het gebied van onderzoek naar neuromusculaire aandoen...
-
Muskelmessung mit quantitativer MRT: Neue Studie in Neurology stärkt die Evidenz für MRT-Biomarker bei SBMA
LINKÖPING, Schweden--(BUSINESS WIRE)--AMRA Medical gibt die Veröffentlichung neuer Forschungsergebnisse in Neurology bekannt. Die Studie untersucht das Potenzial der quantitativen Ganzkörper-MRT, den Krankheitsverlauf bei der spinalen und bulbären Muskelatrophie (SBMA) zu erfassen, einer seltenen, fortschreitenden neuromuskulären Erkrankung. Zudem wurde die Studie für das Titelbild der Ausgabe ausgewählt und verschafft dieser bedeutenden Forschungsarbeit zu neuromuskulären Erkrankungen zusätzli...
-
Resumen: Exploración de los músculos mediante resonancia magnética cuantitativa: un nuevo estudio publicado en Neurology amplía las pruebas que respaldan el uso de biomarcadores de resonancia magnética en SBMA
LINKÖPING, Suecia--(BUSINESS WIRE)--AMRA Medical tiene el placer de anunciar la publicación de un nuevo estudio en Neurology que demuestra el potencial de la resonancia magnética cuantitativa de cuerpo entero para medir la progresión de la atrofia muscular espinal y bulbar (SBMA), una enfermedad neuromuscular rara y progresiva. El estudio también fue seleccionado para aparecer en la portada de este número, lo que aporta una mayor visibilidad a este importante trabajo en el ámbito de la investig...
-
Mesure des muscles par IRM quantitative : une nouvelle étude publiée dans la revue Neurology enrichit les données sur l'utilisation des biomarqueurs IRM dans la SBMA
LINKÖPING, Suède--(BUSINESS WIRE)--AMRA Medical est heureuse d'annoncer la publication d'une nouvelle étude dans la revue Neurology démontrant le potentiel de l'IRM quantitative corps entier pour mesurer la progression de l'amyotrophie spinale et bulbaire (ASB), une maladie neuromusculaire rare et progressive. Cette étude a également été choisie pour faire la couverture de la revue, donnant ainsi plus de visibilité à ces importants travaux dans le domaine de la recherche sur les maladies neurom...
-
Paradromics Receives FDA Approval to Expand BCI Access to Personal Computing Devices in Connect-One™ Clinical Study
AUSTIN, Texas--(BUSINESS WIRE)--Paradromics Inc., a leader in neurotechnology and developer of the world’s highest-data-rate brain-computer interface platform, today announced that it has received an approval letter from the U.S. Food and Drug Administration (FDA) expanding the types of computing devices that may be used with its investigational BCI system. The approval creates a pathway for Paradromics to support compatible personal, internet-connected devices through Convey™, its user-facing s...
-
Measuring Muscles with Quantitative MRI: New Study Published in Neurology Expands the Evidence for Using MRI Biomarkers in SBMA
LINKÖPING, Sweden--(BUSINESS WIRE)--Measuring Muscles with Quantitative MRI. AMRA Medical Announces New Study Published in Neurology Expands the Evidence for Using MRI Biomarkers in SBMA...
-
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
GUILFORD, Conn.--(BUSINESS WIRE)--Peer-reviewed NEURO PMR results and 3,000+ office brain MRI scans support growing use of the Swoop system across neurology practices....
